Product Information
ESCITALOPRAM 20 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0639 per EA under NDC 82009003710. Its NADAC has been published 164 times since May 10, 2023.
Strength
20 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009003710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA090939On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 20 MG TABLET has been published 164 times since May 10, 2023, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0639 per EA |
|---|---|
| All-time high | $0.0892 (Feb 14, 2024) |
| All-time low | $0.0548 (Nov 20, 2024) |
| 52-week high | $0.0766 |
| 52-week low | $0.0605 |
| Median price | $0.0763 |
| Average price | $0.0739 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the escitalopram oxalate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 20 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0639 per EA (NDC 82009003710), effective Jun 24, 2026.
How has the price of ESCITALOPRAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 20 MG TABLET has declined 26.6%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 20 MG TABLET?
Since May 10, 2023, the NADAC for ESCITALOPRAM 20 MG TABLET has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0892 (Feb 14, 2024), with a median of $0.0763 per EA.
Are there cheaper alternatives to ESCITALOPRAM 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ESCITALOPRAM 20 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ESCITALOPRAM 20 MG TABLET?
ESCITALOPRAM 20 MG TABLET (NDC 82009003710) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification